Featured Abstracts
Review key findings and research highlights presented at major industry conferences and events.
Featured Content
AAPM
NTCP Modeling of Dose to Bladder and Urethra with Urinary Symptoms Following Prostate Cyberknife SBRT.
AAPM
Optimized Dosimetric Planning for Trigeminal Neuralgia Using CyberKnife S7 Precision TPS with Volo Optimizer
AAPM
Precise Measurement of Leaf Open Time in TomoTherapy Using Advanced Plastic Scintillators
Featured Case Studies
Transition to the Radixact® System for Pediatric Total Body Irradiation (TBI) Treatment
A 6-year-old boy presented with a high white blood cell count and a mediastinal mass. He was diagnosed with high-risk T-cell acute lymphoblastic leukemia (ALL) and treated in the ALLTogether1 trial1. During induction therapy with regimen B, the patient continued to have high levels of minimal residual disease (MRD). Subsequently,
Precision and Innovation: Insights on a robust radiation oncology practice from a long-term CyberKnife® System user
According to the World Health Organization, in 2050 more than 35 million new cancer cases will be diagnosed, a 77 percent increase from the estimated 20 million cases in 20221. Men are anticipated to be the hardest hit, with a study in the journal Cancer finding that global cancer cases
Deep Inspiration Breath Hold Using VitalHold™ on the Radixact® System
A 45-year-old female patient was diagnosed with pT2N1M0 invasive ductal carcinoma of the left breast. The patient underwent breast conservation surgery with axillary dissection, followed by chemotherapy and radiation therapy. Radiation therapy was delivered by the Radixact® System, the latest generation of the TomoTherapy® Platform with surface guided radiotherapy (SGRT)
1021: RE-START: A National Registry Including Patients Undergoing Reirradiation After Previous RT for Prostate Cancer. A Study on Behalf of AIRO
Giulio Francolini et al. | ESTRO | 2025
